LA JOLLA, CA and HOUSTON, TX--(Marketwired - Nov 15, 2016) - Panther Biotechnology, Inc. (OTC PINK: PBYA), or Panther, is pleased to announce today that it has executed a share exchange agreement to merge with Brown Technical Media Corp., or Brown, a privately held corporation in Houston, Texas. Brown and Panther have executed a share exchange agreement whereby all of the outstanding capital stock of Brown will be exchanged for 32,000,000 shares of Panther common stock. Brown will be managed as a second division of Panther. The Board of Directors and Management of both companies voted unanimously to approve the transaction.
Brown Technical Media Corp. is positioning itself to be the leading online aggregator of compliance, career advancement, and training content for tradesman and technical experts in a wide variety of professions. Brown's mission is to disrupt and defragment the many disparate companies in the eLearning, standards and codes market place, which currently is collectively valued at over $100 billion globally and growing. Brown is changing the landscape for small and medium size businesses by providing consistent, high quality training materials usually only available to enterprise level companies. Brown's strategy is to both grow its current revenue base organically while concurrently acquiring synergistic companies in the multiple industries that Brown is currently servicing.
Brown is an established name in the industry of standards and codes, a market which is currently estimated at $1.5 billion in the United States. Brown has developed a technology driven asset and intellectual property portfolio. Further, it has strategically launched into the $100 billion plus synergistic eLearning space to support training, education and certification for the industries purchasing its technical products. This has led to initial growth driven by web conversion from 0.25% to 2.5% in only two years and increased internet based revenue by approximately 300% in year 1 and approximately 700% in year 2. From before 2013 to after 2016, visitors per month increased 169%, orders per month increased 684% and the conversion ratio increased by 186%. From before 2013 to after 2016, annual store sales increased 124% and online sales increased 683%. Brown intends to take advantage of this momentum by growing into one of the leading eLearning companies for vocational industries through both organic growth and strategic acquisitions.
"We are unaware of any other company in our space that is aggregating both eLearning with codes and standards," stated Noah Davis, President and Chief Operating Officer of Panther. "We can now offer synergistic small businesses an opportunity to be part of a larger and growing organization, improve their economies of scale and expand their revenue growth in the industries that they service. We have already identified several companies that share these characteristics and have initiated exploratory discussions to acquire them. Further, we are in the process of launching new websites and online services, initiating new publications and training opportunities, working on several strategic partnerships and hiring additional technology managers and corporate sales reps."
"We are incredibly fortunate to be a part of this unique business opportunity," stated Evan Levine, Chief Executive Officer of Panther. "Panther shareholders will now participate in this inimitable growth area in which we know of no other public company that offers similar sub-industry exposure via the public trading of common stock."
In addition to Brown shareholders exchanging all of their capital stock for shares of Panther, the exchange agreement affords an earn-out provision for the shareholders of Panther whereby they will receive up to 24,000,000 additional shares of Panther common stock if certain clinical milestones are reached in the development of Transferrin Doxorubicin, the Company's lead oncological therapeutic. Panther will set a record date for earn-out shares before the end of 2016.
Steven M. Plumb, the Chief Financial Officer of Panther is the Chief Financial Officer and Chairman of the Board of Directors and a shareholder of Brown and owns 36.85% of Brown's outstanding common stock at the time of the Exchange Agreement. Evan M. Levine, the Chief Executive Officer of Panther owns 18.75% of Brown's outstanding common stock.
ABOUT PANTHER BIOTECHNOLOGY, INC.
Panther Biotechnology, Inc. has been an entity focused on the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and antiviral disorders for the last two years. Upon completion of the merger with Brown, Panther will continue its regulatory effort with the goal of seeking a partner or financing for its anticipated phase 2a study and also focus its efforts on growing its revenues in the eLearning, standards and codes industries via both organic growth and acquisitions.